BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 28643955)

  • 1. Diffusion tensor imaging of normal-appearing white matter in patients with neuromyelitis optica spectrum disorder and multiple sclerosis.
    Kim SH; Kwak K; Hyun JW; Joung A; Lee SH; Choi YH; Lee JM; Kim HJ
    Eur J Neurol; 2017 Jul; 24(7):966-973. PubMed ID: 28643955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of probabilistic tractography and tract-based spatial statistics for assessing optic radiation damage in patients with autoimmune inflammatory disorders of the central nervous system.
    Kuchling J; Backner Y; Oertel FC; Raz N; Bellmann-Strobl J; Ruprecht K; Paul F; Levin N; Brandt AU; Scheel M
    Neuroimage Clin; 2018; 19():538-550. PubMed ID: 29984162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of diffusion tensor imaging (DTI) tissue characterization parameters in white matter tracts of patients with multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD).
    Chen X; Roberts N; Zheng Q; Peng Y; Han Y; Luo Q; Feng J; Luo T; Li Y
    Eur Radiol; 2024 Jan; ():. PubMed ID: 38175221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatigue in multiple sclerosis: The contribution of occult white matter damage.
    Bisecco A; Caiazzo G; d'Ambrosio A; Sacco R; Bonavita S; Docimo R; Cirillo M; Pagani E; Filippi M; Esposito F; Tedeschi G; Gallo A
    Mult Scler; 2016 Nov; 22(13):1676-1684. PubMed ID: 26846989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microstructural white matter abnormalities in multiple sclerosis and neuromyelitis optica spectrum disorders: Evaluation by advanced diffusion imaging.
    Kato S; Hagiwara A; Yokoyama K; Andica C; Tomizawa Y; Hoshino Y; Uchida W; Nishimura Y; Fujita S; Kamagata K; Hori M; Hattori N; Abe O; Aoki S
    J Neurol Sci; 2022 May; 436():120205. PubMed ID: 35259556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive brain microstructural damage in patients with multiple sclerosis but not in patients with neuromyelitis optica spectrum disorder: A cross-sectional and follow-up tract-based spatial statistics study.
    Chen X; Roberts N; Zheng Q; Peng Y; Han Y; Luo Q; Zeng C; Wang J; Luo T; Li Y
    Mult Scler Relat Disord; 2021 Oct; 55():103178. PubMed ID: 34384989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of normal-appearing white matter tract integrity in multiple sclerosis: a diffusion kurtosis imaging study.
    de Kouchkovsky I; Fieremans E; Fleysher L; Herbert J; Grossman RI; Inglese M
    J Neurol; 2016 Jun; 263(6):1146-55. PubMed ID: 27094571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of teriflunomide on gray and white matter brain pathology in multiple sclerosis using volumetric and diffusion-tensor imaging MRI measures.
    Zivadinov R; Bergsland N; Hagemeier J; Carl E; Kolb H; Hojnacki D; Weinstock-Guttman B
    J Neurol Sci; 2018 May; 388():175-181. PubMed ID: 29627017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of dimethyl fumarate on gray and white matter pathology in subjects with relapsing multiple sclerosis: a longitudinal study.
    Zivadinov R; Hagemeier J; Bergsland N; Tavazzi E; Weinstock-Guttman B
    Eur J Neurol; 2018 Mar; 25(3):584-e36. PubMed ID: 29316038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. White matter microstructural alterations in clinically isolated syndrome and multiple sclerosis.
    Huang J; Liu Y; Zhao T; Shu N; Duan Y; Ren Z; Sun Z; Liu Z; Chen H; Dong H; Li K
    J Clin Neurosci; 2018 Jul; 53():27-33. PubMed ID: 29754967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain parenchymal damage in neuromyelitis optica spectrum disorder - A multimodal MRI study.
    Pache F; Zimmermann H; Finke C; Lacheta A; Papazoglou S; Kuchling J; Wuerfel J; Hamm B; Ruprecht K; Paul F; Brandt AU; Scheel M
    Eur Radiol; 2016 Dec; 26(12):4413-4422. PubMed ID: 27012555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normal-appearing white matter demyelination in neuromyelitis optica spectrum disorder.
    Jeong IH; Choi JY; Kim SH; Hyun JW; Joung A; Lee J; Kim HJ
    Eur J Neurol; 2017 Apr; 24(4):652-658. PubMed ID: 28233435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of switching from glatiramer acetate 20 mg/daily to glatiramer acetate 40 mg three times a week on gray and white matter pathology in subjects with relapsing multiple sclerosis: A longitudinal DTI study.
    Zivadinov R; Bergsland N; Hagemeier J; Tavazzi E; Ramasamy DP; Durfee J; Cherneva M; Carl E; Carl J; Kolb C; Hojnacki D; Weinstock-Guttman B
    J Neurol Sci; 2018 Apr; 387():152-156. PubMed ID: 29571854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. White Matter Abnormalities in Multiple Sclerosis Evaluated by Quantitative Synthetic MRI, Diffusion Tensor Imaging, and Neurite Orientation Dispersion and Density Imaging.
    Hagiwara A; Kamagata K; Shimoji K; Yokoyama K; Andica C; Hori M; Fujita S; Maekawa T; Irie R; Akashi T; Wada A; Suzuki M; Abe O; Hattori N; Aoki S
    AJNR Am J Neuroradiol; 2019 Oct; 40(10):1642-1648. PubMed ID: 31515218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping white matter damage distribution in neuromyelitis optica spectrum disorders with a multimodal MRI approach.
    Cacciaguerra L; Rocca MA; Storelli L; Radaelli M; Filippi M
    Mult Scler; 2021 May; 27(6):841-854. PubMed ID: 32672089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of normal-appearing white matter in multiple sclerosis using quantitative susceptibility mapping in conjunction with diffusion tensor imaging.
    Yu FF; Chiang FL; Stephens N; Huang SY; Bilgic B; Tantiwongkosi B; Romero R
    Neuroradiology; 2019 Jan; 61(1):71-79. PubMed ID: 30539215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. White matter involvement beyond the optic nerves in CRION as assessed by diffusion tensor imaging.
    Colpak AI; Kurne AT; Oguz KK; Has AC; Dolgun A; Kansu T
    Int J Neurosci; 2015 Jan; 125(1):10-7. PubMed ID: 24588222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiate aquaporin-4 antibody negative neuromyelitis optica spectrum disorders from multiple sclerosis by multimodal advanced MRI techniques.
    Zhang N; Sun J; Wang Q; Qin W; Zhang X; Qi Y; Yang L; Shi FD; Yu C
    Mult Scler Relat Disord; 2020 Jun; 41():102035. PubMed ID: 32200338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of patients with relapsing-remitting multiple sclerosis using tract-based spatial statistics analysis: diffusion kurtosis imaging.
    Li HQ; Yin B; Quan C; Geng DY; Yu H; Bao YF; Liu J; Li YX
    BMC Neurol; 2018 Aug; 18(1):108. PubMed ID: 30086721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuromyelitis optica spectrum disorder and multiple sclerosis: Differentiation by a multimodal approach.
    Ota M; Sato N; Okamoto T; Noda T; Araki M; Yamamura T; Kunugi H
    Mult Scler Relat Disord; 2015 Nov; 4(6):515-20. PubMed ID: 26590657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.